Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03368157 · ClinicalTrials.gov registry record
PREG-MS: New England MS Pregnancy Registry
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 168
- Enrollment target
NCT03368157 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 168 participants.
The verdict
NCT03368157 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 168 participants
- Enrollment target
Study Summary
The purpose of the study is to develop a detailed pregnancy registry of patients with Multiple Sclerosis in the New England states. Women with a diagnosis of MS that are either pregnant or actively planning to become pregnant are eligible to participate. The study will solely take place through phone interviews. One of the study coordinator at the Partners MS Center will contact the participant for an intake phone interview where general information about the individual, their pregnancy and their MS will be collected. Thereafter the coordinator will contact the participant every 3 months for 20 minutes follow up interviews. After birth, the coordinator will collect information on the growth and development of the participant's baby. Pediatric interviews will be conducted at 2, 4, 6, 9, 12, 18, 24, 36 months. Information from the participant's neurologist and obstetrician, as well as information from the baby's pediatrician, will be made available to the study staff at regular intervals throughout the duration of the study. Through this study, the investigators hope to learn more about the effects of MS on pregnancy and pediatric development, and about the effects of pregnancy on the course of MS.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2017-04-07 |
| Est. Completion | 2022-12-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03368157
The ClinicalTrials.gov registry entry for NCT03368157 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03368157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03368157 about?
NCT03368157 is a clinical study titled "PREG-MS: New England MS Pregnancy Registry". The purpose of the study is to develop a detailed pregnancy registry of patients with Multiple Sclerosis in the New England states. Women with a diagnosis of MS that are either pregnant or actively planning to become pregnant are eligible to participate. The study will solely take place through pho...
What is the current status of trial NCT03368157?
This trial is currently completed. The enrollment target is 168 participants. The study started on 2017-04-07. Estimated completion is 2022-12-07.
Who is sponsoring clinical trial NCT03368157?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.